Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
about
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
description
im Juli 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 July 1996
@en
wetenschappelijk artikel
@nl
name
Specific P53 mutations are ass ...... icin in breast cancer patients
@en
Specific P53 mutations are ass ...... icin in breast cancer patients
@nl
type
label
Specific P53 mutations are ass ...... icin in breast cancer patients
@en
Specific P53 mutations are ass ...... icin in breast cancer patients
@nl
prefLabel
Specific P53 mutations are ass ...... icin in breast cancer patients
@en
Specific P53 mutations are ass ...... icin in breast cancer patients
@nl
P50
P356
P1433
P1476
Specific P53 mutations are ass ...... icin in breast cancer patients
@en
P2093
B Smith-Sørensen
P2888
P304
P356
10.1038/NM0796-811
P50
P577
1996-07-01T00:00:00Z